Ritter Pharmaceuticals Inc (RTTR)

[THREE-DAY-TRADER]

They're low on cash, so everyone should wait until after they announce a round of financing (dilution) or strike a strategic deal.
My rule is never trade these things, particularly biotechs/pharma unless they already have nearly a year's worth of cash burn to reduce risk that typically crashes a stock while trading it. .
$RTTR only had $2 mill in November's qtr report. They need about $10 million or more to be sufficient for one year to reduce risk of a bad news stock offering that typically crashes a stock.

In addition to low cash, they have to deal with being de-listed which is apparently pending a review:
https://ih.advfn.com/stock-market/NASDAQ/ritter-pharmaceuticals-RTTR/stock-news/81226873/current-report-filing-8-k